Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,1325 USD | +2,32% | +1,92% | -5,36% |
Omzet 2022 | 32,26 mln. 30,17 mln. | Omzet 2023 | 34,16 mln. 31,94 mln. | Marktkapitalisatie | 29,4 mln. 27,5 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 8 mln. 7,48 mln. | Nettowinst (verlies) 2023 | 3 mln. 2,81 mln. | EV/omzet 2022 | 0,92 x |
Nettoliquiditeiten 2022 | 5,75 mln. 5,38 mln. | Nettoliquiditeiten 2023 | 3,94 mln. 3,69 mln. | EV/omzet 2023 | 0,75 x |
K/w-verhouding 2022 |
4,73
x | K/w-verhouding 2023 |
9,34
x | Werknemers | 53 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 77,76% |
Recentste transcriptie over Elite Pharmaceuticals, Inc.
1 dag | +2,32% | ||
1 week | +1,92% | ||
Lopende maand | -14,13% | ||
1 maand | -13,06% | ||
3 maanden | -30,26% | ||
6 maanden | +10,42% | ||
Lopend jaar | -5,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 01-08-13 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 01-07-09 |
Christopher Dick
PSD | President | 69 | 01-11-02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 23-10-09 |
Barry Dash
BRD | Director/Board Member | 93 | 01-04-05 |
Davis Caskey
BRD | Director/Board Member | 76 | 28-04-16 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,1325 | +2,32% | 290 097 |
25-04-24 | 0,1295 | +2,53% | 215 550 |
24-04-24 | 0,1263 | +2,52% | 1 124 880 |
23-04-24 | 0,1232 | -3,14% | 798 573 |
22-04-24 | 0,1272 | -2,15% | 611 836 |
uitgestelde koers OTC Markets, 26 april 2024 om 21:59 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-5,36% | 142 mln. | |
+19,62% | 43,34 mld. | |
+20,44% | 21,96 mld. | |
+10,86% | 14,09 mld. | |
+13,07% | 13,64 mld. | |
+37,46% | 11,43 mld. | |
-8,59% | 6,86 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+8,46% | 5,22 mld. |